vs
Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and Western Union CO (WU). Click either name above to swap in a different company.
Western Union CO is the larger business by last-quarter revenue ($982.7M vs $608.1M, roughly 1.6× Hims & Hers Health, Inc.). On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (3.8% vs 0.0%). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (38.8% CAGR vs -1.9%).
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
The Western Union Company is an American multinational financial services corporation headquartered in Denver, Colorado.
HIMS vs WU — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $608.1M | $982.7M |
| Net Profit | — | $64.7M |
| Gross Margin | 65.2% | — |
| Operating Margin | 21.9% | 12.5% |
| Net Margin | — | 6.6% |
| Revenue YoY | 3.8% | 0.0% |
| Net Profit YoY | — | -47.6% |
| EPS (diluted) | $-0.40 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $608.1M | $982.7M | ||
| Q4 25 | $617.8M | $972.0M | ||
| Q3 25 | $599.0M | $985.3M | ||
| Q2 25 | $544.8M | $983.6M | ||
| Q1 25 | $586.0M | $938.7M | ||
| Q4 24 | $481.1M | $1.0B | ||
| Q3 24 | $401.6M | $993.4M | ||
| Q2 24 | $315.6M | $1.0B |
| Q1 26 | — | $64.7M | ||
| Q4 25 | $20.6M | $114.4M | ||
| Q3 25 | $15.8M | $139.6M | ||
| Q2 25 | $42.5M | $122.1M | ||
| Q1 25 | $49.5M | $123.5M | ||
| Q4 24 | $26.0M | $385.7M | ||
| Q3 24 | $75.6M | $264.8M | ||
| Q2 24 | $13.3M | $141.0M |
| Q1 26 | 65.2% | — | ||
| Q4 25 | 71.9% | 33.6% | ||
| Q3 25 | 73.8% | 34.7% | ||
| Q2 25 | 76.4% | 34.6% | ||
| Q1 25 | 73.5% | 34.0% | ||
| Q4 24 | 76.8% | 35.0% | ||
| Q3 24 | 79.2% | 34.2% | ||
| Q2 24 | 81.3% | 35.0% |
| Q1 26 | 21.9% | 12.5% | ||
| Q4 25 | 1.5% | 19.1% | ||
| Q3 25 | 2.0% | 20.5% | ||
| Q2 25 | 4.9% | 19.6% | ||
| Q1 25 | 9.9% | 18.9% | ||
| Q4 24 | 3.9% | 17.5% | ||
| Q3 24 | 5.6% | 16.6% | ||
| Q2 24 | 3.5% | 18.7% |
| Q1 26 | — | 6.6% | ||
| Q4 25 | 3.3% | 11.8% | ||
| Q3 25 | 2.6% | 14.2% | ||
| Q2 25 | 7.8% | 12.4% | ||
| Q1 25 | 8.4% | 13.2% | ||
| Q4 24 | 5.4% | 37.9% | ||
| Q3 24 | 18.8% | 26.7% | ||
| Q2 24 | 4.2% | 13.8% |
| Q1 26 | $-0.40 | $0.41 | ||
| Q4 25 | $0.08 | $0.36 | ||
| Q3 25 | $0.06 | $0.43 | ||
| Q2 25 | $0.17 | $0.37 | ||
| Q1 25 | $0.20 | $0.36 | ||
| Q4 24 | $0.10 | $1.14 | ||
| Q3 24 | $0.32 | $0.78 | ||
| Q2 24 | $0.06 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $222.3M | $909.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $446.2M | $910.5M |
| Total Assets | $2.3B | $8.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $222.3M | $909.2M | ||
| Q4 25 | $228.6M | $1.2B | ||
| Q3 25 | $345.8M | $947.8M | ||
| Q2 25 | $1.1B | $1.0B | ||
| Q1 25 | $273.7M | $1.3B | ||
| Q4 24 | $220.6M | $1.5B | ||
| Q3 24 | $165.5M | $1.1B | ||
| Q2 24 | $129.3M | $1.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.9B | ||
| Q3 25 | — | $2.5B | ||
| Q2 25 | — | $2.5B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | — | $2.1B |
| Q1 26 | $446.2M | $910.5M | ||
| Q4 25 | $540.9M | $957.8M | ||
| Q3 25 | $581.0M | $925.4M | ||
| Q2 25 | $562.7M | $883.6M | ||
| Q1 25 | $549.3M | $939.4M | ||
| Q4 24 | $476.7M | $968.9M | ||
| Q3 24 | $440.1M | $652.7M | ||
| Q2 24 | $362.0M | $440.8M |
| Q1 26 | $2.3B | $8.1B | ||
| Q4 25 | $2.2B | $8.3B | ||
| Q3 25 | $2.2B | $7.8B | ||
| Q2 25 | $1.9B | $8.0B | ||
| Q1 25 | $891.7M | $8.3B | ||
| Q4 24 | $707.5M | $8.4B | ||
| Q3 24 | $602.3M | $7.7B | ||
| Q2 24 | $480.5M | $8.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.01× | ||
| Q3 25 | — | 2.70× | ||
| Q2 25 | — | 2.83× | ||
| Q1 25 | — | 2.61× | ||
| Q4 24 | — | 3.04× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 4.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $89.4M | $109.0M |
| Free Cash FlowOCF − Capex | $53.0M | — |
| FCF MarginFCF / Revenue | 8.7% | — |
| Capex IntensityCapex / Revenue | — | 4.8% |
| Cash ConversionOCF / Net Profit | — | 1.68× |
| TTM Free Cash FlowTrailing 4 quarters | $60.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $89.4M | $109.0M | ||
| Q4 25 | $61.3M | $135.4M | ||
| Q3 25 | $148.7M | $260.4M | ||
| Q2 25 | $-19.1M | $-300.0K | ||
| Q1 25 | $109.1M | $148.2M | ||
| Q4 24 | $86.4M | $134.0M | ||
| Q3 24 | $85.3M | $212.1M | ||
| Q2 24 | $53.6M | $-33.8M |
| Q1 26 | $53.0M | — | ||
| Q4 25 | $-2.5M | $115.5M | ||
| Q3 25 | $79.3M | $252.7M | ||
| Q2 25 | $-69.5M | $-7.8M | ||
| Q1 25 | $50.1M | $144.8M | ||
| Q4 24 | $59.5M | $119.7M | ||
| Q3 24 | $79.4M | $205.1M | ||
| Q2 24 | $47.6M | $-38.9M |
| Q1 26 | 8.7% | — | ||
| Q4 25 | -0.4% | 11.9% | ||
| Q3 25 | 13.2% | 25.6% | ||
| Q2 25 | -12.8% | -0.8% | ||
| Q1 25 | 8.5% | 15.4% | ||
| Q4 24 | 12.4% | 11.8% | ||
| Q3 24 | 19.8% | 20.6% | ||
| Q2 24 | 15.1% | -3.8% |
| Q1 26 | — | 4.8% | ||
| Q4 25 | 10.3% | 2.0% | ||
| Q3 25 | 11.6% | 0.8% | ||
| Q2 25 | 9.3% | 0.8% | ||
| Q1 25 | 10.1% | 0.4% | ||
| Q4 24 | 5.6% | 1.4% | ||
| Q3 24 | 1.5% | 0.7% | ||
| Q2 24 | 1.9% | 0.5% |
| Q1 26 | — | 1.68× | ||
| Q4 25 | 2.98× | 1.18× | ||
| Q3 25 | 9.43× | 1.87× | ||
| Q2 25 | -0.45× | -0.00× | ||
| Q1 25 | 2.20× | 1.20× | ||
| Q4 24 | 3.32× | 0.35× | ||
| Q3 24 | 1.13× | 0.80× | ||
| Q2 24 | 4.03× | -0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HIMS
| United States Revenue | $529.9M | 87% |
| Rest of the World Revenue | $78.2M | 13% |
WU
Segment breakdown not available.
